Drug Type Antisense oligonucleotides |
Synonyms microRNA-328 antisense oligonucleotide - Sunhawk Vision Biotech, SHJ 002, SHJ-002 |
Target |
Mechanism miR-328 inhibitors(microRNA 328 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Corneal Ulcer | Phase 2 | TW | 01 May 2024 | |
Sjogren's Syndrome | Phase 2 | TW | 01 May 2024 | |
Dry Eye Syndromes | Phase 2 | AU | 08 Feb 2023 | |
Dry Eye Syndromes | Phase 2 | TW | 08 Feb 2023 | |
Dry Eye Syndromes | Phase 2 | TH | 08 Feb 2023 | |
Myopia | Phase 1 | TW | 02 Jul 2021 |